The Strategy for Choosing a New-Generation Proton Pump Inhibitor Dexlansoprazole in the Treatment of Gastroesophageal Reflux Disease

Medical Council
doi 10.21518/2079-701x-2018-3-32-41
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Remedium, Ltd.


Related search